Naseem Zojwalla

Entity
Individual
Business address
C/O Olema Pharmaceuticals, Inc., 512 2 Nd Street, 4 Th Floor, 94107 San Francisco, CA
Signature Ownership
/s/ Shane Kovacs, Attorney-in-Fact
All SEC filings
View on sec.gov
Get insider transactions for this reporting owner
Naseem Zojwalla has filed 18 SEC EDGAR filings since 2/3/2022

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing Mar 3, 2025 Feb 28, 2025 001-39712
4 Open Document Open Filing Dec 17, 2024 Dec 16, 2024 001-39712
4 Open Document Open Filing Dec 11, 2024 Dec 9, 2024 001-39712
144 Open Document Open Filing Dec 11, 2024
144 Open Document Open Filing Dec 10, 2024
4 Open Document Open Filing May 28, 2024 May 24, 2024 001-39712
4 Open Document Open Filing Mar 20, 2024 Mar 18, 2024 001-39712
4 Open Document Open Filing Feb 5, 2024 Feb 1, 2024 001-39712
4 Open Document Open Filing Jan 29, 2024 Jan 25, 2024 001-39712
4 Open Document Open Filing Dec 12, 2023 Dec 11, 2023 001-39712
4 Open Document Open Filing Dec 7, 2023 Dec 6, 2023 001-39712
3/A Open Document Open Filing Dec 7, 2023 Dec 7, 2023 001-39712
4 Open Document Open Filing Nov 22, 2023 Nov 20, 2023 001-39712
144 Open Document Open Filing Nov 22, 2023
144 Open Document Open Filing Nov 21, 2023
4 Open Document Open Filing FORM 4 SUBMISSION Feb 2, 2023 Feb 1, 2023 001-39712
4 Open Document Open Filing Feb 3, 2022 Feb 1, 2022 001-39712
3 Open Document Open Filing Feb 3, 2022 Jan 31, 2022 001-39712